Effect of Interventions on Progression of Knee Osteoarthritis - a Comparison of Effect of Glucosamine/Chondroitin or Diacerin Vs Placebo: Measured by Clinical, Radiological and Biochemical Parameters

Trial Profile

Effect of Interventions on Progression of Knee Osteoarthritis - a Comparison of Effect of Glucosamine/Chondroitin or Diacerin Vs Placebo: Measured by Clinical, Radiological and Biochemical Parameters

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Mar 2017

At a glance

  • Drugs Diacerein (Primary) ; Glucosamine/chondroitin sulfate
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Acronyms KAPS
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 09 Mar 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Jul 2017.
    • 24 Feb 2016 Planned End Date changed from 1 Sep 2017 to 1 Oct 2017 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top